STOCK TITAN

Treace Announces Participation in the UBS Global Healthcare Conference

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Treace Medical Concepts (NasdaqGS: TMCI), a medical technology company specializing in surgical treatments for bunions and midfoot deformities through its Lapiplasty® and Adductoplasty® Procedures, announced its participation in the upcoming UBS Global Healthcare Conference. CEO John T. Treace and CFO Mark L. Hair will engage in a fireside chat on November 12, 2024, at 11:45 am ET. The event will be accessible via live webcast and replay on the company's investor relations website.

Loading...
Loading translation...
Argus Session date unavailable
+6.08% session move Open Argus
Details

News Market Reaction – TMCI

The recorded move for TMCI in the trading session of this news was +6.08%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, beginning at approximately 11:45 am ET.

A live webcast and replay of the fireside chat will be available on the Company’s investors relations website at https://investors.treace.com/.

Internet Posting of Information
Treace routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.treace.com. The Company encourages investors and potential investors to consult the Treace website regularly for important information about Treace.

About Treace Medical Concepts

Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, of which Treace estimates 1.1 million are annual surgical candidates. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. To further support the needs of bunion patients, Treace has introduced its Adductoplasty® Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities. The Company continues to expand its footprint in the foot and ankle market with the introduction of its SpeedPlate™ Rapid Compression Implants, an innovative fixation platform with broad versatility across Lapiplasty® and Adductoplasty® procedures, as well as other common bone fusion procedures of the foot. For more information, please visit www.treace.com.

To learn more about Treace, connect with us on LinkedIn, X, Facebook and Instagram.

Contacts:
Treace Medical Concepts
Mark L. Hair
Chief Financial Officer
mhair@treace.net
(904) 373-5940

Investors:
Gilmartin Group
Vivian Cervantes
IR@treace.net


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Treace Medical Concepts (TMCI) presenting at the UBS Global Healthcare Conference?

Treace Medical Concepts (TMCI) will present at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, at 11:45 am ET.

How can investors watch Treace Medical Concepts' (TMCI) UBS Conference presentation?

Investors can watch the live webcast and replay of Treace Medical Concepts' presentation through the company's investor relations website at https://investors.treace.com/.

Who will represent Treace Medical Concepts (TMCI) at the UBS Healthcare Conference?

CEO John T. Treace and CFO Mark L. Hair will represent Treace Medical Concepts in a fireside chat at the UBS Global Healthcare Conference.

Keep reading